115 related articles for article (PubMed ID: 16309241)
1. Head and neck carcinoma cell lines are sensitive to vinflunine in vitro.
Erjala K; Raitanen M; Kulmala J; Grénman R
Anticancer Res; 2005; 25(6B):4363-7. PubMed ID: 16309241
[TBL] [Abstract][Full Text] [Related]
2. Concomitant vinorelbine and radiation in head and neck squamous cell carcinoma in vitro.
Erjala K; Pulkkinen J; Kulmala J; Grénman R
Acta Oncol; 2004; 43(2):169-74. PubMed ID: 15163165
[TBL] [Abstract][Full Text] [Related]
3. Head and neck squamous cell carcinoma is highly sensitive to vinorelbine in Vitro.
Erjala K; Pulkkinen J; Kulmala J; Alanen K; Grenman R
Anticancer Res; 2002; 22(6A):3135-42. PubMed ID: 12530056
[TBL] [Abstract][Full Text] [Related]
4. Concomitant chemoirradiation with vinorelbine and gefitinib induces additive effect in head and neck squamous cell carcinoma cell lines in vitro.
Erjala K; Zhang N; Sundvall M; Kulmala J; Elenius K; Grénman R
Radiother Oncol; 2007 Oct; 85(1):138-45. PubMed ID: 17923163
[TBL] [Abstract][Full Text] [Related]
5. Concurrent use of vinorelbine and gefitinib induces supra-additive effect in head and neck squamous cell carcinoma cell lines.
Erjala K; Raitanen M; Kulmala J; Grénman R
J Cancer Res Clin Oncol; 2007 Mar; 133(3):169-76. PubMed ID: 17021904
[TBL] [Abstract][Full Text] [Related]
6. Vulvar squamous cell carcinoma cell lines are sensitive to paclitaxel in vitro.
Jaakkola M; Rantanen V; Grénman S; Kulmala J; Grénman R
Anticancer Res; 1997; 17(2A):939-43. PubMed ID: 9137431
[TBL] [Abstract][Full Text] [Related]
7. Ex vivo responsiveness of head and neck squamous cell carcinoma to vinorelbine.
Dollner R; Granzow C; Tschop K; Dietz A
Anticancer Res; 2006; 26(3B):2361-5. PubMed ID: 16821617
[TBL] [Abstract][Full Text] [Related]
8. Novel actions of the antitumor drugs vinflunine and vinorelbine on microtubules.
Ngan VK; Bellman K; Panda D; Hill BT; Jordan MA; Wilson L
Cancer Res; 2000 Sep; 60(18):5045-51. PubMed ID: 11016627
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxicity of bleomycin and external radiation in squamous cell cancer cell lines of head and neck.
Jääskelä-Saari HA; Kairemo KJ; Jekunen AP; Pekkola-Heino K; Kulmala J; Ramsay HA; Grenman R
Cancer Detect Prev; 1996; 20(4):279-84. PubMed ID: 8818387
[TBL] [Abstract][Full Text] [Related]
10. Endometrial cancer cell lines are sensitive to paclitaxel.
Rantanen V; Grénman S; Kulmala J; Grénman R
Anticancer Res; 1996; 16(1):475-9. PubMed ID: 8615657
[TBL] [Abstract][Full Text] [Related]
11. Vinflunine, a new vinca alkaloid: cytotoxicity, cellular accumulation and action on the interphasic and mitotic microtubule cytoskeleton of PtK2 cells.
Jean-Decoster C; Brichese L; Barret JM; Tollon Y; Kruczynski A; Hill BT; Wright M
Anticancer Drugs; 1999 Jul; 10(6):537-43. PubMed ID: 10885901
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of C-12' substituted vinflunine derivatives.
Lei XS; Yu XD; Yin L; Liu ZH; Tang PC
Bioorg Med Chem Lett; 2008 Aug; 18(16):4602-5. PubMed ID: 18653334
[TBL] [Abstract][Full Text] [Related]
13. Cisplatin resistance of the HNSCC cell line UT-SCC-26A can be overcome by stimulation of the EGF-receptor.
Mandic R; Rodgarkia-Dara CJ; Krohn V; Wiegand S; Grénman R; Werner JA
Anticancer Res; 2009 Apr; 29(4):1181-7. PubMed ID: 19414362
[TBL] [Abstract][Full Text] [Related]
14. Cell cycle effects of vinflunine, the most recent promising Vinca alkaloid, and its interaction with radiation, in vitro.
Simoens C; Vermorken JB; Korst AE; Pauwels B; De Pooter CM; Pattyn GG; Lambrechts HA; Breillout F; Lardon F
Cancer Chemother Pharmacol; 2006 Aug; 58(2):210-8. PubMed ID: 16317558
[TBL] [Abstract][Full Text] [Related]
15. Preclinical in vivo antitumor activity of vinflunine, a novel fluorinated Vinca alkaloid.
Kruczynski A; Colpaert F; Tarayre JP; Mouillard P; Fahy J; Hill BT
Cancer Chemother Pharmacol; 1998; 41(6):437-47. PubMed ID: 9554586
[TBL] [Abstract][Full Text] [Related]
16. A comparison of thermodynamic parameters for vinorelbine- and vinflunine-induced tubulin self-association by sedimentation velocity.
Lobert S; Ingram JW; Hill BT; Correia JJ
Mol Pharmacol; 1998 May; 53(5):908-15. PubMed ID: 9584218
[TBL] [Abstract][Full Text] [Related]
17. Vinflunine, a novel microtubule inhibitor, suppresses calmodulin interaction with the microtubule-associated protein STOP.
Makarov AA; Tsvetkov PO; Villard C; Esquieu D; Pourroy B; Fahy J; Braguer D; Peyrot V; Lafitte D
Biochemistry; 2007 Dec; 46(51):14899-906. PubMed ID: 18052208
[TBL] [Abstract][Full Text] [Related]
18. Further mechanistic unravelling of the influence of the cell cycle effects on the radiosensitising mechanism of vinflunine, in vitro.
Simoens C; Pauwels B; Vermorken JB; Pattyn GG; Lambrechts HA; Breillout F; Lardon F
Cancer Chemother Pharmacol; 2008 Jul; 62(2):183-93. PubMed ID: 17899084
[TBL] [Abstract][Full Text] [Related]
19. Antimitotic and tubulin-interacting properties of vinflunine, a novel fluorinated Vinca alkaloid.
Kruczynski A; Barret JM; Etiévant C; Colpaert F; Fahy J; Hill BT
Biochem Pharmacol; 1998 Mar; 55(5):635-48. PubMed ID: 9515574
[TBL] [Abstract][Full Text] [Related]
20. Head and neck squamous cell carcinoma cell lines are highly sensitive to the new taxanes, BMS-184476, BMS-188797, in vitro.
Raitanen M; Pulkkinen J; Kulmala J; Grénman R
Anticancer Res; 2004; 24(6):3769-73. PubMed ID: 15736410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
